UHPLC Method Development for Determining Sitagliptin and Dapagliflozin in Lipid-Based Self-Nanoemulsifying Systems as Combined Dose in Commercial Products and its Application to Pharmacokinetic Study of Dapagliflozin in Rats
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Alqahtani, Abdulmohsen A.
Alsaadi, Badr S.
Alanazi, Fars K.
Text and Data Mining valid from 2019-04-01
24 January 2018
12 April 2019